Unresolved disorder model. using A ATOM 115 CG ATYR 15 -8.060 5.779 19.651 0.50 6.02 C Unresolved disorder model. using A ATOM 116 CG BTYR 15 -8.281 6.113 20.086 0.50 5.64 C Unresolved disorder model. using A ATOM 117 CD1ATYR 15 -7.892 5.307 18.353 0.50 5.37 C Unresolved disorder model. using A ATOM 118 CD1BTYR 15 -8.466 6.042 18.701 0.50 5.44 C Unresolved disorder model. using A ATOM 119 CD2ATYR 15 -9.013 6.760 19.879 0.50 5.72 C Unresolved disorder model. using A ATOM 120 CD2BTYR 15 -9.077 7.009 20.809 0.50 5.81 C Unresolved disorder model. using A ATOM 121 CE1ATYR 15 -8.667 5.798 17.305 0.50 5.83 C Unresolved disorder model. using A ATOM 122 CE1BTYR 15 -9.412 6.845 18.052 0.50 5.57 C Unresolved disorder model. using A ATOM 123 CE2ATYR 15 -9.799 7.261 18.843 0.50 7.18 C Unresolved disorder model. using A ATOM 124 CE2BTYR 15 -10.039 7.816 20.167 0.50 6.05 C Unresolved disorder model. using A ATOM 125 CZ ATYR 15 -9.617 6.781 17.561 0.50 5.82 C Unresolved disorder model. using A ATOM 126 CZ BTYR 15 -10.200 7.723 18.792 0.50 5.58 C Unresolved disorder model. using A ATOM 127 OH ATYR 15 -10.399 7.280 16.548 0.50 7.85 O Unresolved disorder model. using A ATOM 128 OH BTYR 15 -11.128 8.509 18.146 0.50 7.51 O Unresolved disorder model. using A ATOM 186 CB AASP 22 -9.514 -9.551 39.636 0.50 17.31 C Unresolved disorder model. using A ATOM 187 CB BASP 22 -9.506 -9.564 39.643 0.50 17.07 C Unresolved disorder model. using A ATOM 188 CG AASP 22 -10.943 -9.061 39.394 0.50 18.53 C Unresolved disorder model. using A ATOM 189 CG BASP 22 -9.394 -10.860 38.825 0.50 17.65 C Unresolved disorder model. using A ATOM 190 OD1AASP 22 -11.163 -7.838 39.235 0.50 18.72 O Unresolved disorder model. using A ATOM 191 OD1BASP 22 -8.347 -11.128 38.201 0.50 16.50 O Unresolved disorder model. using A ATOM 192 OD2AASP 22 -11.861 -9.909 39.380 0.50 20.63 O Unresolved disorder model. using A ATOM 193 OD2BASP 22 -10.376 -11.632 38.818 0.50 19.18 O Unresolved disorder model. using A ATOM 1053 CA AILE 131 -23.432 28.247 26.099 0.50 14.76 C Unresolved disorder model. using A ATOM 1054 CA BILE 131 -23.396 28.321 26.227 0.50 15.06 C Unresolved disorder model. using A ATOM 1057 CB AILE 131 -23.932 27.094 25.187 0.50 14.14 C Unresolved disorder model. using A ATOM 1058 CB BILE 131 -23.912 26.923 25.782 0.50 14.87 C Unresolved disorder model. using A ATOM 1059 CG1AILE 131 -25.359 26.706 25.587 0.50 14.84 C Unresolved disorder model. using A ATOM 1060 CG1BILE 131 -23.657 26.662 24.298 0.50 13.95 C Unresolved disorder model. using A ATOM 1061 CG2AILE 131 -23.002 25.878 25.232 0.50 13.08 C Unresolved disorder model. using A ATOM 1062 CG2BILE 131 -25.389 26.734 26.162 0.50 15.61 C Unresolved disorder model. using A ATOM 1063 CD1AILE 131 -26.110 25.915 24.555 0.50 15.35 C Unresolved disorder model. using A ATOM 1064 CD1BILE 131 -23.660 25.182 23.952 0.50 12.72 C Unresolved disorder model. using A ATOM 1221 OG ASER 151 -16.293 34.760 9.280 0.50 14.32 O Unresolved disorder model. using A ATOM 1222 OG BSER 151 -14.455 36.015 8.640 0.50 14.55 O Unresolved disorder model. using A ATOM 1607 CA AARG 199 -22.552 5.170 25.154 0.50 16.87 C Unresolved disorder model. using A ATOM 1608 CA BARG 199 -22.541 5.169 25.155 0.50 16.83 C Unresolved disorder model. using A ATOM 1611 CB AARG 199 -21.078 5.002 25.505 0.50 16.08 C Unresolved disorder model. using A ATOM 1612 CB BARG 199 -21.060 5.037 25.507 0.50 16.01 C Unresolved disorder model. using A ATOM 1613 CG AARG 199 -20.529 3.691 24.992 0.50 16.96 C Unresolved disorder model. using A ATOM 1614 CG BARG 199 -20.346 3.957 24.702 0.50 16.38 C Unresolved disorder model. using A ATOM 1615 CD AARG 199 -19.096 3.791 24.532 0.50 16.46 C Unresolved disorder model. using A ATOM 1616 CD BARG 199 -18.838 4.010 24.885 0.50 16.35 C Unresolved disorder model. using A ATOM 1617 NE AARG 199 -18.729 2.571 23.821 0.50 17.02 N Unresolved disorder model. using A ATOM 1618 NE BARG 199 -18.412 3.706 26.253 0.50 17.52 N Unresolved disorder model. using A ATOM 1619 CZ AARG 199 -18.847 2.388 22.507 0.50 16.72 C Unresolved disorder model. using A ATOM 1620 CZ BARG 199 -18.069 2.498 26.697 0.50 18.75 C Unresolved disorder model. using A ATOM 1621 NH1AARG 199 -19.308 3.355 21.713 0.50 12.91 N Unresolved disorder model. using A ATOM 1622 NH1BARG 199 -18.100 1.440 25.894 0.50 20.17 N Unresolved disorder model. using A ATOM 1623 NH2AARG 199 -18.486 1.226 21.983 0.50 16.57 N Unresolved disorder model. using A ATOM 1624 NH2BARG 199 -17.692 2.344 27.959 0.50 19.21 N Unresolved disorder model. using A ATOM 1696 CA AILE 210 -15.857 21.172 9.813 0.50 10.62 C Unresolved disorder model. using A ATOM 1697 CA BILE 210 -15.766 21.187 9.994 0.50 10.52 C Unresolved disorder model. using A ATOM 1700 CB AILE 210 -15.833 22.291 10.879 0.50 10.22 C Unresolved disorder model. using A ATOM 1701 CB BILE 210 -15.400 21.886 11.341 0.50 9.91 C Unresolved disorder model. using A ATOM 1702 CG1AILE 210 -14.740 22.041 11.918 0.50 10.34 C Unresolved disorder model. using A ATOM 1703 CG1BILE 210 -16.678 22.355 12.059 0.50 10.27 C Unresolved disorder model. using A ATOM 1704 CG2AILE 210 -17.222 22.467 11.507 0.50 10.57 C Unresolved disorder model. using A ATOM 1705 CG2BILE 210 -14.411 23.017 11.148 0.50 10.88 C Unresolved disorder model. using A ATOM 1706 CD1AILE 210 -14.527 23.214 12.858 0.50 10.89 C Unresolved disorder model. using A ATOM 1707 CD1BILE 210 -16.520 22.642 13.548 0.50 10.64 C Unresolved disorder model. using A ATOM 1846 CG1AILE 229 5.799 1.935 11.250 0.50 9.59 C Unresolved disorder model. using A ATOM 1847 CG1BILE 229 5.893 2.020 11.228 0.50 9.54 C Unresolved disorder model. using A ATOM 1849 CD1AILE 229 6.428 2.949 12.182 0.50 11.02 C Unresolved disorder model. using A ATOM 1850 CD1BILE 229 5.257 1.026 12.175 0.50 10.39 C Unresolved disorder model. using A ATOM 2110 CG1AILE 262 11.861 15.563 -16.671 0.50 10.66 C Unresolved disorder model. using A ATOM 2111 CG1BILE 262 11.896 15.527 -16.634 0.50 10.96 C Unresolved disorder model. using A ATOM 2113 CD1AILE 262 12.847 14.618 -17.354 0.50 10.85 C Unresolved disorder model. using A ATOM 2114 CD1BILE 262 11.620 16.566 -17.706 0.50 12.37 C Unresolved disorder model. using A ATOM 2182 CG ATYR 271 -8.244 12.972 -12.918 0.50 8.29 C Unresolved disorder model. using A ATOM 2183 CG BTYR 271 -8.011 13.280 -12.542 0.50 6.45 C Unresolved disorder model. using A ATOM 2184 CD1ATYR 271 -8.384 13.054 -11.524 0.50 9.53 C Unresolved disorder model. using A ATOM 2185 CD1BTYR 271 -7.792 13.712 -11.239 0.50 5.76 C Unresolved disorder model. using A ATOM 2186 CD2ATYR 271 -9.074 12.082 -13.603 0.50 8.91 C Unresolved disorder model. using A ATOM 2187 CD2BTYR 271 -9.005 12.339 -12.771 0.50 5.77 C Unresolved disorder model. using A ATOM 2188 CE1ATYR 271 -9.335 12.271 -10.843 0.50 9.22 C Unresolved disorder model. using A ATOM 2189 CE1BTYR 271 -8.548 13.214 -10.195 0.50 5.56 C Unresolved disorder model. using A ATOM 2190 CE2ATYR 271 -10.014 11.299 -12.935 0.50 9.56 C Unresolved disorder model. using A ATOM 2191 CE2BTYR 271 -9.770 11.830 -11.734 0.50 6.77 C Unresolved disorder model. using A ATOM 2192 CZ ATYR 271 -10.144 11.395 -11.561 0.50 9.26 C Unresolved disorder model. using A ATOM 2193 CZ BTYR 271 -9.541 12.271 -10.453 0.50 5.51 C Unresolved disorder model. using A ATOM 2194 OH ATYR 271 -11.086 10.611 -10.924 0.50 10.90 O Unresolved disorder model. using A ATOM 2195 OH BTYR 271 -10.308 11.766 -9.443 0.50 7.32 O Unresolved disorder model. using A ATOM 2298 CA AASP 285 -0.368 24.473 -22.635 0.50 14.61 C Unresolved disorder model. using A ATOM 2299 CA BASP 285 -0.360 24.478 -22.640 0.50 14.68 C Unresolved disorder model. using A ATOM 2302 CB AASP 285 -0.044 25.685 -23.505 0.50 15.77 C Unresolved disorder model. using A ATOM 2303 CB BASP 285 -0.012 25.672 -23.529 0.50 15.93 C Unresolved disorder model. using A ATOM 2304 CG AASP 285 0.653 26.789 -22.733 0.50 16.53 C Unresolved disorder model. using A ATOM 2305 CG BASP 285 -1.127 26.694 -23.596 0.50 17.35 C Unresolved disorder model. using A ATOM 2306 OD1AASP 285 0.607 26.778 -21.482 0.50 15.95 O Unresolved disorder model. using A ATOM 2307 OD1BASP 285 -1.685 27.043 -22.532 0.50 19.13 O Unresolved disorder model. using A ATOM 2308 OD2AASP 285 1.242 27.675 -23.382 0.50 19.06 O Unresolved disorder model. using A ATOM 2309 OD2BASP 285 -1.438 27.151 -24.714 0.50 19.08 O Unresolved disorder model. using A ATOM 2487 CA AASP 307 7.551 19.566 -18.010 0.50 10.40 C Unresolved disorder model. using A ATOM 2488 CA BASP 307 7.538 19.551 -18.020 0.50 10.59 C Unresolved disorder model. using A ATOM 2491 CB AASP 307 8.876 19.166 -18.659 0.50 11.20 C Unresolved disorder model. using A ATOM 2492 CB BASP 307 8.807 19.080 -18.732 0.50 11.56 C Unresolved disorder model. using A ATOM 2493 CG AASP 307 8.811 19.107 -20.165 0.50 12.86 C Unresolved disorder model. using A ATOM 2494 CG BASP 307 9.690 20.211 -19.181 0.50 14.19 C Unresolved disorder model. using A ATOM 2495 OD1AASP 307 7.736 19.344 -20.751 0.50 14.66 O Unresolved disorder model. using A ATOM 2496 OD1BASP 307 9.170 21.312 -19.459 0.50 16.42 O Unresolved disorder model. using A ATOM 2497 OD2AASP 307 9.868 18.828 -20.768 0.50 15.23 O Unresolved disorder model. using A ATOM 2498 OD2BASP 307 10.917 19.986 -19.262 0.50 16.82 O Unresolved disorder model. using A ATOM 2513 CE ALYS 309 8.692 16.473 -21.845 0.50 20.66 C Unresolved disorder model. using A ATOM 2514 CE BLYS 309 8.590 16.607 -21.776 0.50 20.57 C Unresolved disorder model. using A ATOM 2515 NZ ALYS 309 8.580 17.278 -23.094 0.50 22.63 N Unresolved disorder model. using A ATOM 2516 NZ BLYS 309 9.983 16.080 -21.635 0.50 21.91 N Unresolved disorder model. using A ATOM 2820 CA AVAL 349 2.272 -3.152 -3.739 0.50 10.62 C Unresolved disorder model. using A ATOM 2821 CA BVAL 349 2.287 -3.148 -3.737 0.50 10.96 C Unresolved disorder model. using A ATOM 2824 CB AVAL 349 1.598 -4.133 -4.754 0.50 11.00 C Unresolved disorder model. using A ATOM 2825 CB BVAL 349 1.651 -4.104 -4.775 0.50 11.33 C Unresolved disorder model. using A ATOM 2826 CG1AVAL 349 0.634 -3.417 -5.713 0.50 9.09 C Unresolved disorder model. using A ATOM 2827 CG1BVAL 349 2.574 -4.343 -5.946 0.50 12.77 C Unresolved disorder model. using A ATOM 2828 CG2AVAL 349 2.631 -4.982 -5.485 0.50 11.83 C Unresolved disorder model. using A ATOM 2829 CG2BVAL 349 1.318 -5.433 -4.114 0.50 11.96 C Unresolved disorder model. using A ATOM 3169 CA AARG 393 -5.623 -3.147 -18.080 0.50 7.92 C Unresolved disorder model. using A ATOM 3170 CA BARG 393 -5.603 -3.128 -18.135 0.50 8.22 C Unresolved disorder model. using A ATOM 3173 CB AARG 393 -5.145 -3.741 -19.406 0.50 8.83 C Unresolved disorder model. using A ATOM 3174 CB BARG 393 -5.116 -3.514 -19.531 0.50 9.34 C Unresolved disorder model. using A ATOM 3175 CG AARG 393 -3.940 -4.675 -19.243 0.50 8.75 C Unresolved disorder model. using A ATOM 3176 CG BARG 393 -4.142 -4.682 -19.557 0.50 10.37 C Unresolved disorder model. using A ATOM 3177 CD AARG 393 -3.390 -5.199 -20.567 0.50 10.70 C Unresolved disorder model. using A ATOM 3178 CD BARG 393 -3.788 -5.098 -20.990 0.50 12.96 C Unresolved disorder model. using A ATOM 3179 NE AARG 393 -4.421 -5.846 -21.380 0.50 11.38 N Unresolved disorder model. using A ATOM 3180 NE BARG 393 -4.962 -5.259 -21.857 0.50 14.09 N Unresolved disorder model. using A ATOM 3181 CZ AARG 393 -4.603 -7.158 -21.481 0.50 12.23 C Unresolved disorder model. using A ATOM 3182 CZ BARG 393 -5.548 -6.419 -22.153 0.50 14.62 C Unresolved disorder model. using A ATOM 3183 NH1AARG 393 -3.819 -8.001 -20.824 0.50 11.92 N Unresolved disorder model. using A ATOM 3184 NH1BARG 393 -5.079 -7.564 -21.660 0.50 15.92 N Unresolved disorder model. using A ATOM 3185 NH2AARG 393 -5.578 -7.625 -22.256 0.50 13.05 N Unresolved disorder model. using A ATOM 3186 NH2BARG 393 -6.607 -6.430 -22.961 0.50 13.01 N Unresolved disorder model. using A ATOM 3291 CA ASER 407 -14.264 -15.353 -3.095 0.50 12.55 C Unresolved disorder model. using A ATOM 3292 CA BSER 407 -14.246 -15.357 -3.100 0.50 12.75 C Unresolved disorder model. using A ATOM 3295 CB ASER 407 -15.242 -16.325 -2.441 0.50 13.60 C Unresolved disorder model. using A ATOM 3296 CB BSER 407 -15.180 -16.388 -2.460 0.50 13.86 C Unresolved disorder model. using A ATOM 3297 OG ASER 407 -14.614 -17.000 -1.371 0.50 13.89 O Unresolved disorder model. using A ATOM 3298 OG BSER 407 -16.404 -15.799 -2.066 0.50 14.91 O Unresolved disorder model. using A ATOM 3319 CA AGLU 410 -11.348 -14.147 -7.027 0.50 9.55 C Unresolved disorder model. using A ATOM 3320 CA BGLU 410 -11.346 -14.133 -7.040 0.50 9.51 C Unresolved disorder model. using A ATOM 3323 CB AGLU 410 -11.062 -15.313 -6.059 0.50 10.51 C Unresolved disorder model. using A ATOM 3324 CB BGLU 410 -11.039 -15.285 -6.080 0.50 10.50 C Unresolved disorder model. using A ATOM 3325 CG AGLU 410 -10.142 -14.976 -4.894 0.50 12.42 C Unresolved disorder model. using A ATOM 3326 CG BGLU 410 -10.147 -14.916 -4.921 0.50 12.30 C Unresolved disorder model. using A ATOM 3327 CD AGLU 410 -9.700 -16.206 -4.100 0.50 14.13 C Unresolved disorder model. using A ATOM 3328 CD BGLU 410 -9.837 -16.107 -4.045 0.50 13.95 C Unresolved disorder model. using A ATOM 3329 OE1AGLU 410 -9.490 -17.282 -4.704 0.50 15.34 O Unresolved disorder model. using A ATOM 3330 OE1BGLU 410 -10.730 -16.965 -3.874 0.50 14.25 O Unresolved disorder model. using A ATOM 3331 OE2AGLU 410 -9.546 -16.092 -2.864 0.50 15.86 O Unresolved disorder model. using A ATOM 3332 OE2BGLU 410 -8.701 -16.188 -3.528 0.50 16.74 O Unresolved disorder model. using A ATOM 3389 CA ASER 417 -8.331 -13.224 -16.955 0.50 12.08 C Unresolved disorder model. using A ATOM 3390 CA BSER 417 -8.338 -13.248 -16.951 0.50 12.03 C Unresolved disorder model. using A ATOM 3393 CB ASER 417 -7.581 -13.968 -15.842 0.50 12.31 C Unresolved disorder model. using A ATOM 3394 CB BSER 417 -7.656 -14.064 -15.857 0.50 12.29 C Unresolved disorder model. using A ATOM 3395 OG ASER 417 -6.261 -14.310 -16.240 0.50 13.80 O Unresolved disorder model. using A ATOM 3396 OG BSER 417 -7.197 -13.220 -14.832 0.50 12.68 O Unresolved disorder model. using A ATOM 3404 CA AARG 419 -11.516 -13.179 -21.351 0.50 12.98 C Unresolved disorder model. using A ATOM 3405 CA BARG 419 -11.486 -13.198 -21.381 0.50 13.01 C Unresolved disorder model. using A ATOM 3408 CB AARG 419 -12.969 -12.765 -21.035 0.50 13.10 C Unresolved disorder model. using A ATOM 3409 CB BARG 419 -12.968 -12.856 -21.161 0.50 13.21 C Unresolved disorder model. using A ATOM 3410 CG AARG 419 -14.045 -13.827 -21.242 0.50 14.29 C Unresolved disorder model. using A ATOM 3411 CG BARG 419 -13.854 -14.029 -20.785 0.50 14.26 C Unresolved disorder model. using A ATOM 3412 CD AARG 419 -14.310 -14.626 -19.979 0.50 14.16 C Unresolved disorder model. using A ATOM 3413 CD BARG 419 -15.307 -13.682 -20.973 0.50 14.34 C Unresolved disorder model. using A ATOM 3414 NE AARG 419 -15.569 -15.366 -20.048 0.50 16.28 N Unresolved disorder model. using A ATOM 3415 NE BARG 419 -16.168 -14.839 -20.756 0.50 16.02 N Unresolved disorder model. using A ATOM 3416 CZ AARG 419 -15.834 -16.456 -19.343 0.50 16.83 C Unresolved disorder model. using A ATOM 3417 CZ BARG 419 -17.405 -14.954 -21.225 0.50 16.07 C Unresolved disorder model. using A ATOM 3418 NH1AARG 419 -14.927 -16.951 -18.506 0.50 14.99 N Unresolved disorder model. using A ATOM 3419 NH1BARG 419 -17.933 -13.986 -21.953 0.50 15.06 N Unresolved disorder model. using A ATOM 3420 NH2AARG 419 -17.012 -17.053 -19.473 0.50 18.92 N Unresolved disorder model. using A ATOM 3421 NH2BARG 419 -18.113 -16.049 -20.966 0.50 17.38 N Unresolved disorder model. using A ATOM 3781 CA AILE 466 -15.932 -2.162 -2.600 0.50 10.02 C Unresolved disorder model. using A ATOM 3782 CA BILE 466 -15.834 -2.179 -2.790 0.50 10.31 C Unresolved disorder model. using A ATOM 3785 CB AILE 466 -15.911 -3.277 -3.671 0.50 9.68 C Unresolved disorder model. using A ATOM 3786 CB BILE 466 -15.439 -2.851 -4.148 0.50 10.03 C Unresolved disorder model. using A ATOM 3787 CG1AILE 466 -14.855 -2.994 -4.738 0.50 9.31 C Unresolved disorder model. using A ATOM 3788 CG1BILE 466 -16.700 -3.267 -4.930 0.50 10.51 C Unresolved disorder model. using A ATOM 3789 CG2AILE 466 -17.305 -3.467 -4.273 0.50 9.17 C Unresolved disorder model. using A ATOM 3790 CG2BILE 466 -14.503 -4.029 -3.948 0.50 10.95 C Unresolved disorder model. using A ATOM 3791 CD1AILE 466 -14.608 -4.171 -5.659 0.50 8.70 C Unresolved disorder model. using A ATOM 3792 CD1BILE 466 -16.458 -3.633 -6.396 0.50 11.81 C Unresolved disorder model. using A ATOM 3931 CG1AILE 485 5.769 17.066 -4.092 0.50 9.00 C Unresolved disorder model. using A ATOM 3932 CG1BILE 485 5.824 17.001 -4.093 0.50 9.08 C Unresolved disorder model. using A ATOM 3934 CD1AILE 485 6.370 16.053 -5.024 0.50 9.76 C Unresolved disorder model. using A ATOM 3935 CD1BILE 485 5.168 18.024 -5.015 0.50 10.13 C Unresolved disorder model. using A ATOM 4021 CA ALYS 497 -8.132 24.448 -2.097 0.50 13.00 C Unresolved disorder model. using A ATOM 4022 CA BLYS 497 -8.180 24.461 -2.104 0.50 12.90 C Unresolved disorder model. using A ATOM 4025 CB ALYS 497 -6.674 24.880 -2.310 0.50 13.04 C Unresolved disorder model. using A ATOM 4026 CB BLYS 497 -6.790 25.042 -2.394 0.50 12.89 C Unresolved disorder model. using A ATOM 4027 CG ALYS 497 -6.333 25.259 -3.739 0.50 13.94 C Unresolved disorder model. using A ATOM 4028 CG BLYS 497 -6.599 26.454 -1.842 0.50 13.93 C Unresolved disorder model. using A ATOM 4029 CD ALYS 497 -7.187 26.420 -4.212 0.50 16.20 C Unresolved disorder model. using A ATOM 4030 CD BLYS 497 -5.333 27.105 -2.367 0.50 15.55 C Unresolved disorder model. using A ATOM 4031 CE ALYS 497 -7.057 26.629 -5.703 0.50 17.67 C Unresolved disorder model. using A ATOM 4032 CE BLYS 497 -4.929 28.321 -1.532 0.50 17.79 C Unresolved disorder model. using A ATOM 4033 NZ ALYS 497 -8.025 27.642 -6.189 0.50 19.20 N Unresolved disorder model. using A ATOM 4034 NZ BLYS 497 -6.056 29.011 -0.843 0.50 19.83 N 1